NCT00456937已完成4 期
Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study
BeerYaakov Mental Health Center2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2006年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
- 试验地点
- 2
研究概览
简要总结
SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who suffer from schizophrenia and OCD
排除标准
- •Substance abuse,
- •Serious medical condintions,
- •Being on SSRI treatment
研究者
研究点 (2)
Loading locations...
相似试验
终止
1 期
Treatment Resistant Bipolar DepressionBipolar DepressionNCT00272025Queen's University1
已完成
4 期
DECIFER: Depression and Citalopram In First Episode RecoverySchizophreniform DisorderSchizophreniaNCT01041274NYU Langone Health95
已完成
4 期
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking ClozapineSchizophreniaNCT00056498University of Maryland, Baltimore65
已完成
4 期
Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)SchizophreniaNCT00053703University of North Carolina, Chapel Hill116
已完成
2 期
A dose-finding trial of OPC-34712 in patients with schizophreniaSchizophreniaJPRN-jRCT2080221591Otsuka Pharmaceutical Co., Ltd.447